American Century Companies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

American Century Companies’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-329,152	Closed	-$11M	–	1888
2020 Q2	$11M	Buy	+329,152	New	+$10.5M	0.01%	655
2018 Q2	–	Sell	-87,551	Closed	-$1.59M	–	1390
2018 Q1	$1.59M	Buy	+87,551	New	+$1.46M	﹤0.01%	1029
2016 Q1	–	Sell	-68,356	Closed	-$1.01M	–	1404
2015 Q4	$1.01M	Sell	68,356 -192	-0.3%	-$3.21K	﹤0.01%	1111
2015 Q3	$1.13M	Buy	68,548 +16,641	+32%	+$341K	﹤0.01%	1100
2015 Q2	$1.18M	Buy	+51,907	New	+$1.03M	﹤0.01%	1121
2015 Q1	–	Sell	-30,554	Closed	-$368K	–	1469
2014 Q4	$368K	Buy	30,554 +3,333	+12%	+$38.1K	﹤0.01%	1329
2014 Q3	$309K	Buy	27,221 +311	+1%	+$3.55K	﹤0.01%	1347
2014 Q2	$325K	Buy	+26,910	New	+$318K	﹤0.01%	1380

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

American Century Companies's MNTA Position: Q3 2020 in Review

American Century Companies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 329,152 shares — an estimated $11M sold.

American Century Companies first reported a position in MNTA in Q2 2014 and held it in 8 quarters. The position peaked at $11M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

American Century Companies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
American Century Companies sold 329,152 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $11M.
American Century Companies first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 8 quarters.
American Century Companies's Momenta Pharmaceuticals, Inc. position peaked at $11M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on American Century Companies's 13F filing for Q3 2020, filed 13 Nov 2020.